Evidence map›Paper›PMID 25176528›Full record

ReviewDrug and alcohol dependence2014

Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.

Kelly E Courtney, Lara A Ray

4 registry-linked trialsAbstract readReview
In one paragraph

Review in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 190 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
190citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04449055 nacompletednot on this mapstarted 2020, after this paper: background citation

A Pilot Study of Transcranial Magnetic Stimulation for Treatment of Methamphetamine Use Disorders

TypeinterventionalSponsorRyan M. CarnahanRan2020 to 2022Enrolled19ConditionsStimulant Dependence, Methamphetamine-dependence, Addiction, DrugArmsTranscranial Magnetic Stimulation--DPFC first, MPFC second, Transcranial Magnetic Stimulation--MPFC first, DPFC second
NCT07459244 recruitingnot on this mapstarted 2025, after this paper: background citation

Electrocardiogram Findings in Methamphetamine Use Disorder and Methamphetamine-Induced Psychotic Disorder: A Prospective Observational Cohort Study

TypeobservationalSponsorElazığ Mental Health and Diseases HospitalRan2025 to 2026Enrolled240ConditionsMethamphetamine Use Disorder, Methamphetamine Induced Psychosis
NCT07459257 recruitingnot on this mapstarted 2025, after this paper: background citation

Investigation of Factors Associated With Psychiatric Symptoms in Methamphetamine-Induced Psychotic Disorder: One-Year Longitudinal Study

TypeobservationalSponsorElazığ Mental Health and Diseases HospitalRan2025 to 2026Enrolled150ConditionsMethamphetamine Induced Psychosis
NCT07459270 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Investigation of Factors Associated With Psychiatric Symptoms in Participants Diagnosed With Methamphetamine-Induced Psychotic Disorder With and Without Lifetime Cannabis Use

TypeobservationalSponsorElazığ Mental Health and Diseases HospitalRan2026 to 2026Enrolled90ConditionsMethamphetamine Induced Psychosis, Cannabis Use
3 · Its place in the literature

Who cites it

190 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Bupropion and Naltrexone in Methamphetamine Use Disorder.The New England journal of medicine · 2021
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

130 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kelly E CourtneyDepartment of Psychology, University of California, Los Angeles, United States.
Lara A RayDepartment of Psychology, University of California, Los Angeles, United States; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, United States. Electronic address: lararay@psych.ucla.edu.

Funding

UCLA Training Program in Translational Neuroscience of Drug Abuse (TNDA)T32DA024635 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LARA A. RAY, Kate M Wassum · 2008 to 2026
$6.2M
The Effects of Naltrexone on Neural Responses to Methamphetamine CuesF31DA035604 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COURTNEY, KELLY ELIZABETH · 2013 to 2014
$66k
NIDA NIH HHS F31 DA035604NIDA NIH HHS T32 DA024635
6 · The paper itself

Abstract

backgroundDespite initial reports of a decline in use in the early 2000s, methamphetamine remains a significant public health concern with known neurotoxic and neurocognitive effects to the user. The goal of this review is to update the literature on methamphetamine use and addiction since its assent to peak popularity in 1990s.

methodsWe first review recent epidemiological reports with a focus on methamphetamine accessibility, changes in use and disorder prevalence rates over time, and accurate estimates of the associated burden of care to the individual and society. Second, we review methamphetamine pharmacology literature with emphasis on the structural and functional neurotoxic effects associated with repeated use of the drug. Third, we briefly outline the findings on methamphetamine-related neurocognitive deficits as assessed via behavioral and neuroimaging paradigms. Lastly, we review the clinical presentation of methamphetamine addiction and the evidence supporting the available psychosocial and pharmacological treatments within the context of an addiction biology framework.

conclusionTaken together, this review provides a broad-based update of the available literature covering methamphetamine research over the past two decades and concludes with recommendations for future research.

Indexed as

Amphetamine-Related DisordersCentral Nervous System StimulantsCognitionCost of IllnessHumansMethamphetaminePrevalenceCentral Nervous System StimulantsMethamphetamineAddictionMedication developmentMethamphetamineStimulants

Identifiers

PMID25176528
PMCPMC4164186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.